Presented by Austrade in collaboration with HISA

The Australian digital health community is invited to be part of an accelerated Bio-Bridge initiative making a connection with the world’s largest medical centre in Houston, Texas.

The Bio-Bridge initiative is designed to create new connections between the Australian medtech sector and the world’s largest medical centre – the Texas Medical Centre in Houston, USA.

Australian companies focused on digital health and medical devices will have the opportunity to apply to participate in the Texas Medical Centre Accelerator program (TMCx). There will be two cohorts per year, with the first intake commencing in the US in February 2017.

Industry briefings October 2016

Texas Medical Centre CEO Dr Robert C Robbins and COO William McKeon will present the initiative and discuss US market opportunities for Australian medtech startups/SMEs, followed by one-on-one meetings with invited companies.

24 October – Brisbane

28 October – Melbourne

31 October – Adelaide

To obtain more information and express your interest in attending one of these events, please register here.

Startups and innovative SMEs interested in being part of TMCx can also register their interest here.

About TMC

TMC concentrates its operations and research on genomics, regenerative medicine, innovation, clinical trials and health policy. TMC is seeking to expand its commercialisation capacities through TMCx, an accelerator designed to concentrate on the development of medical devices and technology.